Working... Menu

A Microdose Evaluation Study of ABY-029 in Primary Sarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03154411
Recruitment Status : Recruiting
First Posted : May 16, 2017
Last Update Posted : January 8, 2019
Dartmouth College
Information provided by (Responsible Party):
Eric R. Henderson, Dartmouth-Hitchcock Medical Center

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : May 1, 2019
  Estimated Study Completion Date : December 31, 2019